VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
about
Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathwayNotching on Cancer's Door: Notch Signaling in Brain Tumors.KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis.EGFL7 enhances surface expression of integrin αβ to promote angiogenesis in malignant brain tumors
P2860
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
@en
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
@nl
type
label
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
@en
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
@nl
prefLabel
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
@en
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
@nl
P2093
P2860
P1476
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
@en
P2093
Chunhai Huang
Jingjing Zhang
Xianquan Zhan
Xianrui Yuan
P2860
P304
P577
2014-02-15T00:00:00Z